Christopher W. Schultz
Impact in
-
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
Papers in
- Oncology 19
- Pancreatic and Hepatic Oncology Research 11
- Lung Cancer Research Studies 6
-
- Cancer therapeutics and mechanisms 5
- DNA Repair Mechanisms 4
- RNA modifications and cancer 3
- Co-authors
- Jonathan R. Brody (9 shared papers)Ranjan Preet (1 shared paper)Dan A. Dixon (2 shared papers)Avinoam Nevler (5 shared papers)Anish Thomas (9 shared papers)Michael J. Pishvaian (2 shared papers)Vinodh N. Rajapakse (5 shared papers)Nobuyuki Takahashi (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Annals of Surgical Oncology (2 papers)BMJ Open (1 paper)Genome Medicine (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Christopher W. Schultz
22 papers receiving 495 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 143
- Oncology 252
- Molecular Biology 345
- Epidemiology 66
- Immunology 37
Countries citing papers authored by Christopher W. Schultz
This map shows the geographic impact of Christopher W. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Schultz more than expected).
Fields of papers citing papers by Christopher W. Schultz
This network shows the impact of papers produced by Christopher W. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Schultz. The network helps show where Christopher W. Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher W. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 153 | |
| 2 | 2021 | 75 | |
| 3 | 2022 | 60 | |
| 4 | 2019 | 51 | |
| 5 | 2019 | 44 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2019 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 2 |
About Christopher W. Schultz
Christopher W. Schultz is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 23 papers that have together received 496 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Genomics and Diagnostics (5 papers), DNA Repair Mechanisms (4 papers), RNA modifications and cancer (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Cancer Research (143 citations), Oncology (252 citations), Molecular Biology (345 citations), Epidemiology (66 citations) and Immunology (37 citations). Christopher W. Schultz has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Jonathan R. Brody, Ranjan Preet, Dan A. Dixon, Avinoam Nevler, Anish Thomas, Michael J. Pishvaian, Vinodh N. Rajapakse, Nobuyuki Takahashi, Yves Pommier and Samantha Armstrong. Their work appears in journals such as Molecular Cancer Therapeutics, Annals of Surgical Oncology, BMJ Open, Genome Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.